Variant report
Variant | rs2732605 |
---|---|
Chromosome Location | chr17:44291381-44291382 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:44256443..44258068-chr17:44289991..44291605,2 | K562 | blood: | |
2 | chr17:44268608..44272753-chr17:44287651..44292221,9 | K562 | blood: | |
3 | chr17:44267849..44274041-chr17:44289393..44293083,6 | K562 | blood: | |
4 | chr17:44269986..44273675-chr17:44289063..44291645,3 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000120071 | Chromatin interaction |
ENSG00000214401 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10221243 | 0.83[EUR][1000 genomes] |
rs10514897 | 0.91[AFR][1000 genomes] |
rs10514898 | 0.91[AFR][1000 genomes] |
rs10514901 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs10514903 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs10514904 | 0.91[AFR][1000 genomes];0.91[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs1076222 | 0.91[AFR][1000 genomes] |
rs1107820 | 0.91[AFR][1000 genomes] |
rs11079729 | 0.91[AFR][1000 genomes] |
rs11079733 | 0.84[AFR][1000 genomes];0.93[AMR][1000 genomes];0.90[EUR][1000 genomes] |
rs1117253 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs1122380 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.85[EUR][1000 genomes] |
rs1122381 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs12150064 | 0.91[AFR][1000 genomes] |
rs12150087 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs12150090 | 0.91[AFR][1000 genomes] |
rs12150127 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs12150162 | 0.91[AFR][1000 genomes] |
rs12150319 | 0.91[AFR][1000 genomes] |
rs12150336 | 0.91[AFR][1000 genomes] |
rs12150344 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs12150447 | 0.91[AFR][1000 genomes] |
rs12150542 | 0.91[AFR][1000 genomes] |
rs12150551 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs12150558 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs12150570 | 0.91[AFR][1000 genomes] |
rs12150611 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs12150625 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs12150627 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs12150628 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs12185225 | 0.91[AFR][1000 genomes] |
rs12185243 | 0.91[AFR][1000 genomes] |
rs1358439 | 0.91[AFR][1000 genomes] |
rs1468240 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs1468241 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs1476554 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs1706725 | 0.82[EUR][1000 genomes] |
rs17574425 | 0.91[AFR][1000 genomes] |
rs17574604 | 0.91[AFR][1000 genomes] |
rs17574796 | 0.91[AFR][1000 genomes] |
rs17574824 | 0.91[AFR][1000 genomes] |
rs17575423 | 0.91[AFR][1000 genomes] |
rs17575507 | 1.00[CEU][hapmap];0.91[AFR][1000 genomes] |
rs17575556 | 0.91[AFR][1000 genomes] |
rs17575683 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs17575773 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs17575822 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs17575850 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs17576165 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs17576200 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs17576631 | 0.91[AFR][1000 genomes];0.83[AMR][1000 genomes] |
rs17576695 | 0.91[AFR][1000 genomes];0.89[AMR][1000 genomes] |
rs17576709 | 0.91[AFR][1000 genomes];0.88[AMR][1000 genomes] |
rs17576779 | 0.91[AFR][1000 genomes];0.89[AMR][1000 genomes] |
rs17576842 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs17576870 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs17576954 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs17576989 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs17577024 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs17577052 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs17577094 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.80[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17577159 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs17577313 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs17577369 | 0.91[AMR][1000 genomes] |
rs17577447 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs17577496 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs17577650 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs17577877 | 0.91[AFR][1000 genomes];0.89[AMR][1000 genomes];0.85[EUR][1000 genomes] |
rs17577954 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs17577975 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.84[EUR][1000 genomes] |
rs17653162 | 0.91[AFR][1000 genomes] |
rs17653193 | 0.91[AFR][1000 genomes] |
rs17653211 | 0.91[AFR][1000 genomes] |
rs17653255 | 0.91[AFR][1000 genomes] |
rs17653836 | 0.91[AFR][1000 genomes] |
rs17653889 | 0.91[AFR][1000 genomes] |
rs17653998 | 0.91[AFR][1000 genomes] |
rs17654016 | 0.91[AFR][1000 genomes] |
rs17659731 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs17659743 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs17659881 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs17659953 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs17660017 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs17660065 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs17660132 | 0.91[AFR][1000 genomes];0.84[AMR][1000 genomes] |
rs17660167 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs17660228 | 0.82[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs17660251 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs17660294 | 0.91[AFR][1000 genomes];0.84[AMR][1000 genomes] |
rs17660337 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs17660398 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs17660464 | 0.91[AFR][1000 genomes];0.89[AMR][1000 genomes] |
rs17660488 | 0.91[AFR][1000 genomes];0.89[AMR][1000 genomes] |
rs17660595 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs17660847 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs17660865 | 0.91[AFR][1000 genomes];0.91[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs17660907 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs17660936 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs17661015 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs17661027 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs17661045 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs17661141 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs17661348 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs17661385 | 0.91[AFR][1000 genomes];0.91[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs17661428 | 0.89[AMR][1000 genomes];0.84[EUR][1000 genomes] |
rs17664048 | 1.00[AFR][1000 genomes];0.98[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs1819040 | 0.93[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs1918786 | 1.00[AFR][1000 genomes];0.98[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs1918787 | 0.84[AFR][1000 genomes];0.98[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs1918794 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes] |
rs1966345 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs2141298 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs2266497 | 0.93[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs2316951 | 0.91[AFR][1000 genomes] |
rs2316952 | 0.91[AFR][1000 genomes] |
rs2316953 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs2316954 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs2316955 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs2316956 | 0.81[AFR][1000 genomes] |
rs2429449 | 0.91[AFR][1000 genomes];0.82[AMR][1000 genomes] |
rs2469914 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes] |
rs2532229 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs2532233 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs2532239 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs2532276 | 1.00[AFR][1000 genomes];0.91[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs2532277 | 0.81[AFR][1000 genomes] |
rs2532307 | 1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs2532411 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.99[EUR][1000 genomes] |
rs2532412 | 0.91[AFR][1000 genomes];0.84[AMR][1000 genomes] |
rs2532414 | 1.00[AFR][1000 genomes] |
rs2532416 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs2532417 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes] |
rs2532418 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs2532419 | 0.91[AFR][1000 genomes];0.82[AMR][1000 genomes] |
rs2532423 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.95[EUR][1000 genomes] |
rs2668645 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs2668653 | 0.91[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs2668662 | 1.00[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes] |
rs2668665 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs2668668 | 0.91[AFR][1000 genomes];1.00[AMR][1000 genomes];0.96[EUR][1000 genomes] |
rs2668670 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs2668691 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes] |
rs2668692 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs2668694 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs2668695 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs2696445 | 0.91[AFR][1000 genomes];0.88[AMR][1000 genomes] |
rs2696566 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.84[EUR][1000 genomes] |
rs2696568 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs2696569 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs2696608 | 0.91[AFR][1000 genomes] |
rs2696609 | 0.97[EUR][1000 genomes] |
rs2696610 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes] |
rs2696633 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.90[EUR][1000 genomes] |
rs2696635 | 1.00[AFR][1000 genomes];0.84[AMR][1000 genomes] |
rs2696673 | 1.00[AFR][1000 genomes] |
rs2732601 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs2732606 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732628 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs2732629 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs2732630 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2732631 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes] |
rs2732715 | 0.88[EUR][1000 genomes] |
rs2838 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs2942186 | 0.81[AMR][1000 genomes] |
rs2942187 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs2957296 | 1.00[AFR][1000 genomes] |
rs3087534 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs3110331 | 0.82[AFR][1000 genomes];0.88[AMR][1000 genomes];0.91[EUR][1000 genomes] |
rs34043286 | 0.91[AFR][1000 genomes] |
rs34579536 | 0.91[AFR][1000 genomes] |
rs35833914 | 0.91[AFR][1000 genomes] |
rs36076725 | 0.91[AFR][1000 genomes] |
rs3912060 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs3912061 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs3912062 | 0.91[AFR][1000 genomes];0.83[AMR][1000 genomes] |
rs3912063 | 0.82[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs41382552 | 0.91[AFR][1000 genomes] |
rs41437445 | 0.91[AFR][1000 genomes] |
rs4383188 | 0.91[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs4471723 | 0.91[AFR][1000 genomes];0.90[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs4548919 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs4581739 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs4608377 | 0.91[AFR][1000 genomes] |
rs55653937 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.93[EUR][1000 genomes] |
rs55669501 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs55672516 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs55686102 | 0.93[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs55690782 | 0.91[AFR][1000 genomes] |
rs55692232 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs55714296 | 0.91[AFR][1000 genomes] |
rs55744103 | 0.88[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs55780786 | 0.91[AFR][1000 genomes];0.91[AMR][1000 genomes];0.84[EUR][1000 genomes] |
rs55790833 | 0.91[AFR][1000 genomes] |
rs55794067 | 0.81[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs55802590 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs55825513 | 0.91[AFR][1000 genomes];0.89[AMR][1000 genomes] |
rs55831516 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs55864131 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs55881134 | 0.91[AFR][1000 genomes] |
rs55885063 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs55893711 | 0.91[AFR][1000 genomes] |
rs55900347 | 0.91[AFR][1000 genomes];0.89[AMR][1000 genomes] |
rs55909047 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs55929190 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs55947022 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs55955207 | 0.91[AFR][1000 genomes];0.83[AMR][1000 genomes] |
rs55972730 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs55987700 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs56041778 | 0.86[AMR][1000 genomes] |
rs56100031 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs56119705 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.84[EUR][1000 genomes] |
rs56240678 | 0.89[AMR][1000 genomes] |
rs56257094 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs56273589 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs56318865 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs56323408 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060760 | 0.91[AFR][1000 genomes] |
rs62060761 | 0.91[AFR][1000 genomes] |
rs62060762 | 0.91[AFR][1000 genomes] |
rs62060763 | 0.91[AFR][1000 genomes] |
rs62060764 | 0.91[AFR][1000 genomes] |
rs62060765 | 0.91[AFR][1000 genomes] |
rs62060767 | 0.91[AFR][1000 genomes] |
rs62060768 | 0.91[AFR][1000 genomes] |
rs62060785 | 0.91[AFR][1000 genomes] |
rs62060786 | 0.91[AFR][1000 genomes] |
rs62060787 | 0.91[AFR][1000 genomes] |
rs62060792 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060793 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060794 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060795 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060796 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060797 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060798 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060799 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060800 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060801 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060802 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060809 | 0.91[AFR][1000 genomes];0.84[AMR][1000 genomes] |
rs62060810 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060812 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060834 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060835 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060836 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060837 | 0.91[AFR][1000 genomes];0.81[AMR][1000 genomes] |
rs62060838 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060839 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060840 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060841 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060842 | 0.91[AFR][1000 genomes];0.83[AMR][1000 genomes] |
rs62060843 | 0.81[AFR][1000 genomes] |
rs62060844 | 0.91[AFR][1000 genomes];0.84[AMR][1000 genomes] |
rs62060845 | 0.86[AMR][1000 genomes] |
rs62060846 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060847 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060850 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060851 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060852 | 0.81[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060853 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060855 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060856 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060858 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060859 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62060946 | 0.81[AFR][1000 genomes] |
rs62060947 | 0.81[AFR][1000 genomes] |
rs62061764 | 0.86[AMR][1000 genomes] |
rs62061766 | 0.91[AFR][1000 genomes];0.84[AMR][1000 genomes] |
rs62061767 | 0.91[AFR][1000 genomes];0.84[AMR][1000 genomes] |
rs62061770 | 0.91[AFR][1000 genomes] |
rs62061771 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62061772 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62061788 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62061789 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62061790 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62061791 | 0.91[AFR][1000 genomes];0.84[AMR][1000 genomes] |
rs62061792 | 0.91[AFR][1000 genomes] |
rs62061793 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs62061795 | 0.91[AFR][1000 genomes];0.88[AMR][1000 genomes] |
rs62061796 | 0.91[AFR][1000 genomes];0.89[AMR][1000 genomes] |
rs62061798 | 0.91[AFR][1000 genomes];0.89[AMR][1000 genomes] |
rs62061799 | 0.91[AFR][1000 genomes];0.88[AMR][1000 genomes] |
rs62061802 | 0.91[AFR][1000 genomes];0.89[AMR][1000 genomes] |
rs62061803 | 0.91[AFR][1000 genomes];0.89[AMR][1000 genomes] |
rs62061807 | 0.91[AFR][1000 genomes];0.88[AMR][1000 genomes] |
rs62061808 | 0.91[AFR][1000 genomes];0.89[AMR][1000 genomes] |
rs62061809 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs62061810 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs62061811 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs62061812 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs62061814 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs62061815 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs62061816 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs62061817 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs62061818 | 0.91[AFR][1000 genomes];0.89[AMR][1000 genomes] |
rs62061820 | 0.82[AFR][1000 genomes];0.88[AMR][1000 genomes] |
rs62061821 | 0.91[AFR][1000 genomes];0.91[AMR][1000 genomes] |
rs62061822 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs62061823 | 0.93[AMR][1000 genomes] |
rs62061824 | 0.93[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs62061845 | 0.81[AFR][1000 genomes];0.82[AMR][1000 genomes] |
rs62061847 | 0.93[AMR][1000 genomes] |
rs62061848 | 0.93[AMR][1000 genomes] |
rs62061849 | 0.91[AFR][1000 genomes];0.91[AMR][1000 genomes] |
rs62061850 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs62061851 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs62061852 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs62061853 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs62061854 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs62061855 | 0.91[AMR][1000 genomes];0.81[EUR][1000 genomes] |
rs62061856 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs62061858 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs62061859 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs62062133 | 0.91[AFR][1000 genomes] |
rs62062134 | 0.91[AFR][1000 genomes] |
rs62062136 | 0.91[AFR][1000 genomes] |
rs62062137 | 0.91[AFR][1000 genomes] |
rs62062321 | 0.91[AFR][1000 genomes] |
rs62062322 | 0.91[AFR][1000 genomes] |
rs62062323 | 0.91[AFR][1000 genomes] |
rs62062324 | 0.91[AFR][1000 genomes] |
rs62062325 | 0.91[AFR][1000 genomes] |
rs62063163 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs62063164 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs62063165 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs62063166 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs62063171 | 0.91[AFR][1000 genomes];0.91[AMR][1000 genomes];0.84[EUR][1000 genomes] |
rs62063172 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs62063174 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.84[EUR][1000 genomes] |
rs62063200 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs62063201 | 0.89[AMR][1000 genomes];0.84[EUR][1000 genomes] |
rs62063202 | 0.91[AFR][1000 genomes];0.91[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs62063203 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs62063207 | 0.93[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs62063208 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];0.84[EUR][1000 genomes] |
rs62063212 | 0.93[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs62063234 | 0.91[AFR][1000 genomes] |
rs62063670 | 0.91[AFR][1000 genomes] |
rs62063671 | 0.91[AFR][1000 genomes] |
rs62063672 | 0.91[AFR][1000 genomes] |
rs62063673 | 0.91[AFR][1000 genomes] |
rs62063675 | 0.91[AFR][1000 genomes] |
rs62063676 | 0.91[AFR][1000 genomes] |
rs62063677 | 0.91[AFR][1000 genomes] |
rs62063678 | 0.91[AFR][1000 genomes] |
rs62063680 | 0.91[AFR][1000 genomes] |
rs62063682 | 0.91[AFR][1000 genomes] |
rs62063683 | 0.91[AFR][1000 genomes] |
rs62063684 | 0.91[AFR][1000 genomes] |
rs62070911 | 0.81[AFR][1000 genomes] |
rs62073098 | 0.82[AFR][1000 genomes];0.89[AMR][1000 genomes];0.91[EUR][1000 genomes] |
rs6503457 | 0.83[EUR][1000 genomes] |
rs7207582 | 0.83[EUR][1000 genomes] |
rs727425 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes] |
rs73984689 | 0.91[AMR][1000 genomes] |
rs8070942 | 0.83[EUR][1000 genomes] |
rs876944 | 0.91[AFR][1000 genomes] |
rs974291 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs974292 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs974293 | 0.91[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs974294 | 0.81[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs974295 | 0.81[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs9915547 | 0.82[EUR][1000 genomes] |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv817315 | chr17:43651731-44351152 | Enhancers ZNF genes & repeats Bivalent Enhancer Weak transcription Flanking Active TSS Genic enhancers Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
2 | nsv529777 | chr17:43653227-44351644 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer Strong transcription Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
3 | nsv1067695 | chr17:43655747-44351152 | Weak transcription Active TSS Enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
4 | nsv529378 | chr17:43655747-44351152 | Enhancers Active TSS Strong transcription Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
5 | nsv529778 | chr17:43675408-44351152 | Weak transcription Genic enhancers Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 48 gene(s) | inside rSNPs | diseases |
6 | nsv529780 | chr17:43706686-44485971 | Active TSS Strong transcription Enhancers Weak transcription Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 49 gene(s) | inside rSNPs | diseases |
7 | nsv817460 | chr17:43706886-44351152 | Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Strong transcription Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
8 | nsv529278 | chr17:43706886-44694283 | Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 55 gene(s) | inside rSNPs | diseases |
9 | nsv534157 | chr17:43717703-44345038 | Enhancers Strong transcription Active TSS Bivalent Enhancer Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
10 | nsv529794 | chr17:43717703-44351152 | Weak transcription Strong transcription Bivalent/Poised TSS Active TSS Enhancers Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
11 | nsv948604 | chr17:43741452-44364056 | Strong transcription Flanking Active TSS Weak transcription Enhancers Bivalent/Poised TSS Active TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
12 | nsv529795 | chr17:43751674-44351152 | Flanking Active TSS Strong transcription Enhancers Weak transcription Active TSS Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
13 | nsv949112 | chr17:43763241-44364056 | Weak transcription Transcr. at gene 5' and 3' Strong transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
14 | nsv431716 | chr17:43893020-44868187 | Strong transcription Weak transcription Enhancers Active TSS Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 62 gene(s) | inside rSNPs | diseases |
15 | esv2751685 | chr17:44004972-44789317 | Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer Genic enhancers Strong transcription ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 47 gene(s) | inside rSNPs | diseases |
16 | esv2751686 | chr17:44039564-44364056 | Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Strong transcription Genic enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 34 gene(s) | inside rSNPs | diseases |
17 | nsv431717 | chr17:44075901-44809001 | Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
18 | nsv471698 | chr17:44079479-44378253 | Strong transcription Weak transcription Enhancers Flanking Active TSS Genic enhancers Active TSS ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 35 gene(s) | inside rSNPs | diseases |
19 | nsv431718 | chr17:44094463-44873614 | Weak transcription Strong transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS ZNF genes & repeats Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 55 gene(s) | inside rSNPs | diseases |
20 | esv2751687 | chr17:44094471-44364056 | Enhancers Strong transcription Active TSS Weak transcription Genic enhancers Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
21 | nsv575144 | chr17:44109474-44354796 | Enhancers Strong transcription Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
22 | nsv516807 | chr17:44109474-44793283 | Active TSS Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 43 gene(s) | inside rSNPs | diseases |
23 | nsv431719 | chr17:44111853-44364056 | Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Strong transcription Active TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
24 | esv2751688 | chr17:44115107-44364056 | Strong transcription Enhancers Genic enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
25 | nsv431720 | chr17:44115107-44364056 | Strong transcription Weak transcription Active TSS Enhancers Genic enhancers Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
26 | nsv1063349 | chr17:44116860-44435442 | Enhancers Weak transcription Active TSS Flanking Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 36 gene(s) | inside rSNPs | diseases |
27 | esv2753137 | chr17:44116950-44353885 | Genic enhancers Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
28 | nsv431723 | chr17:44118999-44364056 | Weak transcription Enhancers Genic enhancers Strong transcription Flanking Active TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
29 | nsv575149 | chr17:44131305-44350090 | Enhancers Weak transcription Flanking Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
30 | nsv575150 | chr17:44131305-44354796 | Weak transcription Active TSS Enhancers Flanking Active TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
31 | nsv543359 | chr17:44132076-44792529 | Weak transcription Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Strong transcription Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 43 gene(s) | inside rSNPs | diseases |
32 | nsv431726 | chr17:44135864-44364056 | Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
33 | esv1792966 | chr17:44136000-44422977 | Weak transcription Enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Genic enhancers Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 35 gene(s) | inside rSNPs | diseases |
34 | nsv529718 | chr17:44138513-44694283 | Weak transcription Flanking Active TSS Enhancers Strong transcription ZNF genes & repeats Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 43 gene(s) | inside rSNPs | diseases |
35 | nsv916230 | chr17:44138515-44694311 | Weak transcription Enhancers Active TSS Flanking Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 43 gene(s) | inside rSNPs | diseases |
36 | esv2751689 | chr17:44139662-44364056 | Weak transcription Enhancers Genic enhancers Active TSS Strong transcription Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
37 | esv2751690 | chr17:44139662-44364056 | Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
38 | esv2751691 | chr17:44139662-44795190 | Weak transcription Strong transcription Enhancers Flanking Active TSS Genic enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 44 gene(s) | inside rSNPs | diseases |
39 | esv2751692 | chr17:44139662-44811116 | Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 44 gene(s) | inside rSNPs | diseases |
40 | esv2751693 | chr17:44139682-44364056 | Enhancers Weak transcription Flanking Active TSS Strong transcription Genic enhancers Active TSS ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
41 | esv2751694 | chr17:44139682-44789285 | Enhancers Genic enhancers Weak transcription Active TSS Strong transcription Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 43 gene(s) | inside rSNPs | diseases |
42 | esv2751695 | chr17:44139682-44801340 | Enhancers Active TSS Weak transcription Strong transcription Bivalent Enhancer Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 44 gene(s) | inside rSNPs | diseases |
43 | nsv908311 | chr17:44140748-44329221 | Weak transcription Strong transcription Active TSS Transcr. at gene 5' and 3' Enhancers Genic enhancers ZNF genes & repeats Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 27 gene(s) | inside rSNPs | diseases |
44 | nsv470589 | chr17:44140748-44350089 | Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
45 | nsv575152 | chr17:44140748-44350090 | Flanking Active TSS Active TSS Bivalent/Poised TSS Enhancers Weak transcription Bivalent Enhancer ZNF genes & repeats Genic enhancers Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
46 | nsv908312 | chr17:44140748-44354796 | Weak transcription Enhancers Strong transcription Active TSS Genic enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
47 | nsv908313 | chr17:44140748-44368215 | Weak transcription Strong transcription Active TSS Enhancers Genic enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 34 gene(s) | inside rSNPs | diseases |
48 | nsv908314 | chr17:44140748-44375017 | Weak transcription Enhancers Flanking Active TSS Strong transcription Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 34 gene(s) | inside rSNPs | diseases |
49 | nsv908315 | chr17:44140748-44788310 | Weak transcription Bivalent/Poised TSS Enhancers Strong transcription Active TSS Flanking Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 43 gene(s) | inside rSNPs | diseases |
50 | nsv543362 | chr17:44141175-44792529 | Weak transcription Active TSS Enhancers Flanking Active TSS Genic enhancers Strong transcription ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 43 gene(s) | inside rSNPs | diseases |
SNP | Gene | Cis/trans | Tissue | Source |
---|---|---|---|---|
rs2732605 | KIAA1267 | cis | normal skin | skin_eQTL |
rs2732605 | LOC644246///LOC649063 | cis | lesional skin | skin_eQTL |
rs2732605 | LRRC37A | cis | Frontal Cortex | GTEx |
rs2732605 | KIAA1267 | cis | uninvolved skin | skin_eQTL |
rs2732605 | LOC644246 | cis | uninvolved skin | skin_eQTL |
rs2732605 | MAPK8IP1 | cis | Cerebellum | GTEx |
rs2732605 | KIAA1267 | cis | lesional skin | skin_eQTL |
rs2732605 | LOC644246///LOC649063 | cis | uninvolved skin | skin_eQTL |
rs2732605 | FLJ10120 | cis | normal skin | skin_eQTL |
rs2732605 | ARL17 | Cis_1M | lymphoblastoid | RTeQTL |
rs2732605 | LRRC37A4 | Cis_1M | lymphoblastoid | RTeQTL |
rs2732605 | MAPT | cis | Cerebellum | GTEx |
rs2732605 | LOC474170 | cis | uninvolved skin | skin_eQTL |
rs2732605 | LRRC37A3 | Cis_chr | lymphoblastoid | RTeQTL |
rs2732605 | MAPK8IP1 | trans | lymphoblastoid | RTeQTL |
rs2732605 | LOC644246///LOC649063 | cis | normal skin | skin_eQTL |
rs2732605 | ARHGAP27 | Cis_1M | lymphoblastoid | RTeQTL |
rs2732605 | LOC644246 | Cis_1M | lymphoblastoid | RTeQTL |
rs2732605 | NSF | cis | normal skin | skin_eQTL |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:44271600-44302200 | Weak transcription | Lung | lung |
2 | chr17:44271800-44291600 | Weak transcription | Fetal Muscle Trunk | muscle |
3 | chr17:44271800-44293400 | Weak transcription | Placenta | Placenta |
4 | chr17:44271800-44302000 | Weak transcription | Left Ventricle | heart |
5 | chr17:44271800-44302200 | Weak transcription | Esophagus | oesophagus |
6 | chr17:44272200-44302000 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
7 | chr17:44272400-44294200 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
8 | chr17:44272400-44295800 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
9 | chr17:44272400-44302000 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
10 | chr17:44272600-44292600 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
11 | chr17:44272600-44302000 | Weak transcription | Primary B cells from peripheral blood | blood |
12 | chr17:44273600-44292600 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
13 | chr17:44274000-44301600 | Weak transcription | HUVEC | blood vessel |
14 | chr17:44274800-44291600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr17:44277000-44292000 | Weak transcription | Placenta Amnion | Placenta Amnion |
16 | chr17:44277600-44302200 | Weak transcription | NH-A | brain |
17 | chr17:44278600-44302000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr17:44278600-44302000 | Weak transcription | Right Atrium | heart |
19 | chr17:44279600-44292800 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
20 | chr17:44279600-44301600 | Weak transcription | Ovary | ovary |
21 | chr17:44280600-44301600 | Weak transcription | Colonic Mucosa | Colon |
22 | chr17:44280800-44301600 | Weak transcription | Duodenum Mucosa | Duodenum |
23 | chr17:44281600-44292400 | Weak transcription | Gastric | stomach |
24 | chr17:44281600-44301600 | Weak transcription | Pancreas | Pancrea |
25 | chr17:44282800-44292600 | Weak transcription | Primary monocytes fromperipheralblood | blood |
26 | chr17:44283400-44292400 | Weak transcription | Primary T regulatory cells fromperipheralblood | blood |
27 | chr17:44283600-44292600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
28 | chr17:44283600-44292600 | Weak transcription | Primary B cells from cord blood | blood |
29 | chr17:44283800-44291600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
30 | chr17:44283800-44291600 | Weak transcription | Brain Germinal Matrix | brain |
31 | chr17:44283800-44292600 | Weak transcription | Brain Substantia Nigra | brain |
32 | chr17:44284000-44292000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
33 | chr17:44284000-44292000 | Weak transcription | Fetal Brain Female | brain |
34 | chr17:44284000-44292000 | Weak transcription | Fetal Lung | lung |
35 | chr17:44284000-44292400 | Weak transcription | Fetal Brain Male | brain |
36 | chr17:44284000-44292600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
37 | chr17:44284000-44296800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
38 | chr17:44284200-44292600 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
39 | chr17:44284200-44302200 | Weak transcription | Primary hematopoietic stem cells | blood |
40 | chr17:44284400-44292400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
41 | chr17:44286200-44291400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
42 | chr17:44286200-44291600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
43 | chr17:44286200-44292600 | Weak transcription | H9 Cell Line | embryonic stem cell |
44 | chr17:44286200-44302000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
45 | chr17:44286200-44302400 | Weak transcription | Primary T cells effector/memory enriched fromperipheralblood | blood |
46 | chr17:44286400-44292600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
47 | chr17:44286400-44292600 | Weak transcription | HMEC | breast |
48 | chr17:44286400-44295800 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
49 | chr17:44286600-44291600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
50 | chr17:44286600-44292000 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |